Taiwan's TLC Granted Orphan Status in US for Lymphoma Drug bit.ly/2ec4tRc #China #biotech

Tamasek Invests $250 Million in Columbia Pacific for China Hospitals bit.ly/2eyiogd #China #biotech

MicuRx Starts China Phase III Trial of Novel Antibiotic bit.ly/2eqzLDE #China #biotech

Luye Medical Offers $91 Million for Australian Hospital Chain bit.ly/2eqyWuH #China #biotech

Week in Review: China Healthcare and Pharma Deals bit.ly/2f34whh #China #biotech

Have been reading these lately. ChinaBio® Today always puts together a nice weekly summary of Chinese BioPharma news. chinabiotoday.com/articles/20161…

Thanks Brad Loncar for the mention!

Yisheng Granted US Orphan Drug Designation for Cancer Immunotherapy bit.ly/2eCr7zc #China #biotech

CFDA Addresses "80% of China Trials are Based on Fraudulent Data" Story bit.ly/2f268II #China #biotech

Biohit Oyj OK'd to Start China Production of Cancer Screening Test bit.ly/2erF0Rx #China #biotech

Athenex to Market Five Oncology Products from Beijing Sciecure in US bit.ly/2eSm8Z9 #China #biotech

Pluristem to Raise $30 Million from China's Innovative Medical bit.ly/2dPoKFZ #China #biotech

Kanghua Healthcare to Raise $154 Million in Hong Kong IPO bit.ly/2fkE9DA #China #biotech

WuXi PharmaTech Invests in Unity Biotech's $116 Million Series B bit.ly/2eDNd5p #China #biotech

China Resources Pharma Starts Trading Following $1.8 Billion IPO bit.ly/2ePBQaS #China #biotech

Week in Review: China Resources Pharma Stages $1.8 Billion Hong Kong IPO bit.ly/2fr39JB #China #biotech

Decheng Leads $12 Million Series A in Diagnostics Newco Cirina bit.ly/2e5LtxI #China #biotech

TaiGen Forms $102 Million Hepatitis C JV with YiChang HEC Pharma bit.ly/2f60H8s #China #biotech

Medbanks Joins Up with IMS for China Oncology Big Data Effort bit.ly/2ewRwwu #China #biotech

Xbrane Signs Term Sheet for China Distribution of Cancer Drug bit.ly/2fBReZp #China #biotech